1 filter applied
Evidence in focus: OXINIUM materials science evidence collection
Jo Barraud, PhD, Global Clinical and Medical Affairs, Smith+Nephew. Jul 2022
Evidence in focus: Accelerated fretting and corrosion testing of...
Woodard E, Rister D. Poster presented at: ORS 2021 Annual Meeting; February 12–16, 2021; virtual... May 2022
Evidence in focus: R3™ Acetabular System – 10 year follow-up of...
Yeroushalmi D, Singh V, Maher N, Gabor JA, Zuckerman JD, Schwarzkopf R. HIP International. (2021). Dec 2021
Evidence in focus: Modular DM – is there a risk of fretting corrosion?
J Barraud, PhD, Global Clinical and Medical Affairs, Smith+Nephew. Nov 2021
Evidence in focus: malseating in modular DM - a review of current...
Evidence in focus: OXINIUM/XLPE delivers superior survivorship in...
Global Clinical and Medical Affairs, Smith+Nephew. Nov 2021
Evidence in focus: what does the evidence say for LEGION rTKA?
Dr C Creak PhD. Global Clinical Affairs, Smith & Nephew. Jun 2021
Accelerated fretting and corrosion testing of modular acetabular...
Woodard E and Rister D. ORS 2021.. Apr 2021
How to use the WEREWOLF™ FASTSEAL 6.0 Wand
Evidence in focus: Early clinical, radiological and PROMs with REDAPT...
Moriarty P, Vles G, Haddad F, Konan S. Arch Orthop Trauma Surg (2021. Apr 2021
Top JOURNEY II Surgical Videos
AAHKS 2020: Transformative Technologies for Revision Hip Arthroplasty
Dr Ran Schwarzkopf, Dr Curtis Hartman, and Dr David Watson . Feb 2021
Evidence in focus: When are dual mobility bearings cost effective in...
Khoshbin A, Haddad FS, Ward S, O’hEireamhoin S, Wu J, Nherera L, Atrey A. Bone Joint J (2020). Dec 2020
Evidence in focus: LEGION™ rTKA with OXINIUM™ demonstrates...
National Joint Registry for England, Wales and Northern Ireland (NJR) and PROMs data collected by ... Oct 2020
Sign in or Join
Evidence in focus: Nonmodular stems compared to modular stems
Clair AJ, et al. J Arthroplasty (2019). Aug 2020
2008 - 2022 Smith & Nephew Plc. ◊Trademark of Smith+Nephew Product information is for educational purposes only, and not all products or indications are licensed in every country.